In vivo effects of chromium. by Witmer, C et al.
In Vivo Effects of Chromium
Charlotte Witmer," Ellen Faria," Hyoung-Sook Park,' Nakissa Sadrieh,l
Edward Yurkow," Sean O'Connell,2 Andrea Sirak,3 and Heinz Schleyer4
1Joint Graduate Program in Toxicology, Rutgers University and Robert Wood Johnson Medical School,
Piscataway, New Jersey; 2Department of Surgery, Robert Wood Johnson Hospital, New Brunswick, New
Jersey; 3Block Drug Company, Jersey City, New Jersey; 4Department of Surgery, University of Pennsylvania,
Philadelphia, Pennsylvania
The production of reactive oxygen species on addition of hexavalent chromium (potassium dichromate, K2Cr207) to lung cells in culture was studied
using flow cytometer analysis. A Coulter Epics Profile II flow cytometer was used to detect the formation of reactive oxygen species after K2Cr2O7
was added to A549 cells grown to confluence. The cells were loaded with the dye, 2',7'- dichlorofluorescein diacetate, after which cellular esterases
removed the acetate groups and the dye was trapped intracellularly. Reactive oxygen species oxidized the dye, with resultant fluorescence.
Increased doses of Cr(VI) caused increasing fluorescence (10-fold higher than background at 200 pM). Addition of Cr(I) compounds, as the picoli-
nate or chloride, caused no increased fluorescence. Electron paramagnetic resonance (EPR) spectroscopic studies indicated that three (as yet
unidentified) spectral "signals" of the free radical type were formed on addition of 20, 50, 100, and 200 pM Cr(VI) to the A549 cells in suspension.
Two other EPR "signals" with the characteristics of Cr(V) entities were seen at field values lower than the standard free radical value. Liver micro-
somes from male Sprague-Dawley rats treated intraperitoneally with K2Cr2O7 (130 pmole/kg every 48 hr for six treatments) had decreased activity of
cytochromes P4503A1 and/or 3A2, and 2C1 1. Hepatic microsomes from treated female Sprague-Dawley rats, in contrast, had increased activities of
these isozymes. Lung microsomes from male Sprague-Dawley rats had increased activity of P4502C11. - Environ Health Perspect 102(Suppl
3):169-176 (1994).
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Introduction
Previous studies in our laboratories (1-3)
and those of others (4-6) have shown that
there are several potentially toxic in vitro
effects of hexavalent chromium [Cr(VI)]
which are readily detected. However, some
of these effects are not evident in vivo and
others have not been tested in relevant sys-
tems. For example, it has been shown that
when Cr(VI) compounds are reduced by
H202 and/or glutathione (GSH), the path-
way of reduction is dependent upon the
concentrations of the reductants. The
resultant cellular damage (to DNA) may
depend upon the molar ratios of the
reductants and Cr(VI) compound (4).
Production ofCr(V) species in unidentified
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forms, as well as the formation ofa Cr(V)-
tetraperoxo complex, can be detected with
addition ofCr(VI) to several reductants in
vitro (4,5,7,8). There is evidence that
under slightly alkaline conditions, in vitro,
hydroxyl radicals (-OH) are formed, which
then react with deoxyguanine to initiate
DNA strand breakage (4). The concentra-
tions ofreactants used to demonstrate these
intermediates in vitro have generally been
higher than those found in vivo. The car-
cinogenicity ofchromium compounds also
appears to result from attack on DNA by
Cr(III), formed in situ by the reduction of
Cr(VI). Paradoxically, there are beneficial
effects ofCr(III) on glucose metabolism (9)
and chromium is generally accepted
(although controversially) as being a
required trace element (10). Extracellular
reduction ofCr(VI) to Cr(III), which can-
not readily cross the cell membrane, is cur-
rently perceived as a protection reaction.
The acute toxicity ofCr(VI), which is also
little understood, can result in fatality to
rats after intraperitoneal administration of
several daily doses in the 200 pmole/kg
range (2). This general toxicity must be
separated from the carcinogenicity in stud-
ies ofmechanisms ofaction, and is also not
extensively studied. Current knowledge of
chromate carcinogenicity and toxicity thus
indicates that effects of in vivo exposure to
Cr(VI) compounds depend upon the
uptake and metabolic fate of the chromate
in target organs.
The lung has been well established as
the principal target organ for chromium
carcinogenicity (11-13), and as the site of
some Cr(VI)-induced toxicity (3).
However, little is known of the metabolic
fate ofhexavalent chromium in this organ,
except that many reducing agents, such as
ascorbate and glutathione, are present in
this tissue and can ultimately produce
Cr(III) (14-16). The liver, on the other
hand, is the major site ofxenobiotic metab-
olism in mammals. Effects of Cr(VI) on
the liver enzymes of rats have been shown
in our laboratory to differ in in vitroand in
vivo studies (1,2). Addition of potassium
dichromate (K2Cr207) to microsomal frac-
tions from livers of both male and female
rats of two strains caused significant
decreases in both cytochrome P450 (P450)
content and cytochrome c reductase activ-
ity (a measure of cytochrome P450 reduc-
tase activity). These decreases were found
in vitro in microsomes from untreated rats
as well as in microsomes from rats that had
been treated with inducing agents or with
dichromate prior to removal of the livers
(2). In in vivo studies, intraperitoneal
administration of K2Cr207 (130 pmole/kg
body weight) to rats on alternate days for
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six treatments showed that onlylivers from
male Sprague-Dawley rats exhibited a
decrease in P450 content, while the hepatic
reductase activities remained unchanged in
all rats (4. These results emphasize the fact
that in vitro effects are often not mimicked
in vivo, and indicate the need for further
exploration of in vivo effects of Cr(VI) on
the hepatic enzymes.
We have previously demonstrated that
in the rat less than 2% of orally adminis-
tered hexavalent chromium is absorbed
(17,18). However, lung chromium concen-
tration was measurable (12 lig/g tissue) 24
hr after 14 days of daily treatment with
240 ,imole Cr(VI)/kg (as calcium chro-
mate) (12). Intratracheal administration (45
pmole/kg, which mimics the exposure of
workers in smelting plants, results in rela-
tively high concentrations of chromium in
lung 21 days after the single treatment (8.5
pg/g tissue) (E. Faria and C. Witmer,
unpublished data). We also compared the
effects ofCr(VI) on A549 cells and L1210
cells (19), using the alkaline elution tech-
nique (20). The A549 cells are a cell line
from human lung tissue which has the char-
acteristics ofType II cells, and L1210 cells
are a murine cell line ofleukemic origin. In
this study, 5 pM chromate caused single-
strand breaks as well as DNA-protein
cross-links in A549 cells, but formed only
DNA-protein cross-links in the L1210 cells.
These findings support the premise that
lung tissue and lung cells differ from other
tissues in their response to Cr(VI)-initiated
damage.
On the basis ofthese previous findings,
we have used the A549 lung cells and in
vivo studies in rats to explore the effects of
Cr(VI) exposure in in vivo systems. The
purposes of the present work are to con-
tinue our studies of the effects of Cr(VI)
treatment on the hepatic and lung mixed-
function oxidase enzymes and to determine
whether lung cells in culture respond to
exposure to Cr(VI) compounds by produc-
ing reactive oxygen species and free radicals
(including paramagnetic forms of
chromium), as has been indicated by in
vitro work (21,22). We have also concen-
trated on effects on P450 isozymes in
hepatic and lung microsomes following
treatment of the rats with K2Cr207. The
dose chosen was previously shown to
decrease the total P450 in male Sprague-
Dawley rats (4. To further study the mode
ofaction ofCr(VI) in these in vivosystems,
we used flow cytometry and electron para-
magnetic resonance (EPR) spectroscopy.
Flow cytometry is a powerful tool for
detecting reactive oxygen species (ROS),
which have been implicated in metal-
induced DNA strand breakage in other cell
types (21,22). EPR spectroscopy can be
used to detect, under favorable conditions,
paramagnetic transition metal ion species,
including Cr(V) species, as well as a variety
of free radical entities that may be formed
in these A549 lung cells by reactions with
chromium compounds.
Materials and Methods
Animals and Cells
All rats used in these studies were obtained
from Taconic Farms (Germantown, NY).
They were kept in the animal facility for
acclimatization at least 4 days prior to use
and conditions in the animal facility were
those recommended by the National
Institutes of Health. The animals weighed
between 120 and 200 g when used. Both
food (Purina rodent chow) and water were
supplied ad libitum. All water bottles were
fitted with plastic tips and the food was
added directly to the cages to avoid
chromium contamination. The rats were
kept in plastic cages in groups of three per
cage.
A549 cells were obtained from the
American Type Culture Collection
(Rockville, MD) and were maintained in a
95% air, 5% CO2 atmosphere, in RPMI
1640 medium (Gibco, Grand Island, NY)
at 370C, pH 7.2, with 10% fetal calfserum.
Reagents
Hexavalent chromium compounds
(Na2CrO4, K2Cr2O7) and all other chemi-
cals not specifically noted were obtained
from Fisher Chemical Company
(Somerville, NJ). The 2',7'-dichlorofluores-
cein (DCFH) and the diacetate of DCFH
(DCFH-DA) were purchased from
Molecular Probes (Eugene, OR). All chemi-
cals were of the highest purity available.
Chromium picolinate (98% purity) was
generously donated by the Nutrition 21
Company (San Diego, CA). Testosterone
and testosterone metabolites were obtained
as referenced in Jayyosi et al. (23) and were
were donated to us by Dr. Paul Thomas
(Rutgers University).
TreatmentofAnimals
Potassium dichromate was administered
intraperitoneally to the rats in groups ofat
least three per group at a dose of 130
jimole Cr/kg on alternate days for total of
six treatments. Animals were sacrificed with
ether anesthetic 24 hr after the last dose.
Organs were removed and weighed, and
microsomes were immediatelyprepared.
Prepartion ofMicrosomes
Microsomes were prepared by methods
used routinely in our laboratory (24), and
the microsomal fractions were suspended
in phosphate buffer, pH 7.4 (0.1 M phos-
phate, 0.15 M KCl) so that the resulting
suspensions contained the equivalent of
approximately 15 g of original liver/ml.
The microsomes were either used immedi-
atelyor frozen at -800C for future use.
TestosteroneMetabolism (Assayfor
Actities ofCytohrmeP450
Iszymes)
The isozymes of cytochrome P450
hydroxylate testosterone in a regio- and
stereo-specific manner, and thus the
metabolites are indicative of the specific
isozyme activities. We used the method
described by Jayyosi et al. (23) for this
assay. Specifically, testosterone (0.25
pmole, dissolved in methanol) was incu-
bated in a final volume of1.0 ml of0.05 M
phosphate buffer (pH 7.4, containing 0.15
M KCI and 1 mM EDTA), with liver
microsomes (0.250 mg protein) or lung
microsomes (0.250 mg protein), and an
NADPH-generating system, in a shaking
water bath for 10 and 30 min, respectively,
at 37°C. Each assay was carried out in
duplicate, and the appropriate blanks were
run. The reaction was stopped by the addi-
tion of methylene chloride and an aliquot
ofthe organic layer (containing the hydrox-
ylated metabolites) was dried under nitro-
gen and then dissolved in the mobile phase
and analyzed by using high-pressure liquid
chromatography (HPLC). The HPLC col-
umn was a reverse-phase C,8 column, used
as described by Jayyosi et al. (23) to sepa-
rate testosterone, androstenedione and the
eight monohydroxylated testosterone iso-
mers at room temperature. The isomers
were identified by comigration with
authentic standards. It should be noted
that, in this assay, the microsomes used
were from the same animals as those used
to study the in vitro effects of dichromate
(4.
Generation ofReactiveOxygenSpecies
The Coulter Epics Profile II flowcytometer
was used to study the Cr(VI)-induced for-
mation of reactive oxygen species (ROS),
such as H202 and hydroperoxides, by mea-
suring the fluorescence of the oxidized
form of 2',7'-dichlorofluorescein (DCF).
This dye is fluorescent only in the oxidized
state. The reduced dye (DCFH) is intro-
duced into the cells and is oxidized to its
fluorescent form by any ROS produced
after Cr(VI) addition. The fluorescence
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intensity is thus directly proportional to the
ROS produced. To carry out these experi-
ments, A549 cells were grown to conflu-
ence, harvested by centrifugation at 1000g
for 10 min, and suspended in phosphate
buffer, pH 7.4 (0.1 M, containing 0.15 M
KCl) at a concentration of2 x 106 cells/mi.
The reduced nonfluorescent dye (DCFH),
as the diacetate (DCFH-DA), which is
nonpolar and enters the cells rapidly (25)
was added to the cells (5 liM final concen-
tration) and the mixture incubated for 30
min at 37°C. Intracellular esterases imme-
diately hydrolyze the DCFH-DA leaving a
resultant polar compound which is trapped
in the cells in the reduced, nonfluorescent
state. K2Cr207 (in phosphate-buffered
saline) at several concentrations (20, 100,
200 PM) was then added in 200-jil vol-
umes. (Total volume in the tube was 2.2
ml). The resulting ROS were determined
at 10-min intervals for 60 min. The excita-
tion wavelength of the dye is 488 nm; the
emission wavelength, 525 nm. The data
(number of cells containing the oxidized
fluorescent dye and the log fluorescence)
were automatically recorded on a disc in
the cytometer, and histograms of the data
were generated using Epics Cytologic.
Control samples contained either buffer
(no chromium compound) or the trivalent
compound, CrCl3, which does not enter
cells readily, or chromium picolinate (dis-
solved in methanol), which enters the cells
(both at 200 piM). Positive controls were
H202 or phorbol myristate. To detect any
direct oxidation ofthe reduced dye by the
hexavalent chromium, K2Cr207 was added
to the reduced dye directly in the Perkin-
Elmer fluorimeter (Perkin-Elmer, South
Plainfield, NJ) with a 525-nm bandpass fil-
ter, and any fluorescence ofthe mixture at
525 nm was recorded for 60 min.
Experiments were repeated three times
with the same results.
Electron Parmanetic Resonance
The electron paramagnetic resonance
(EPR) data were generated using a Varian
E-109 spectrometer (Vairan Instruments,
Palo Alto, CA) to detect spectra from free
radicals and/or paramagnetic Cr(V) species,
following addition ofhexavalent chromium
(as K2Cr207) to the A549 lung cells. The
cells were grown to confluence and har-
vested immediately prior to the EPR exper-
iments. The cells were resuspended in
physiologic saline (by dilution of a stock
solution in phosphate-buffered saline,
unless otherwise designated) at a concen-
tration of 1 to 2 x 107 cells in a total vol-
ume of 0.18 ml, and chromate was added
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Figure 1. Hydroxylation of testosterone by cytochrome P450 isozymes in hepatic microsomes from dichromate-treated
male Sprague-Dawley rats. Microsomes were prepared from dichromate-treated male rats as described in thetext. The
testosterone assay and identification of metabolites were carried out as described byJayyosi et al. (21). The abscissa
indicatesthe position ofhydroxylation ofthetestosterone.
in avolume of0.250 ml. The concentrations
ofchromate added are given in the legends
for Figures 7 to 9. Immediatelyafter addition
ofthe chromate and mixing, the suspension
was transferred to an EPR tube of the "flat
cell" type (with minimal dimension in the
E-field plane). The cell was inserted in the
pretuned microwave cavity, and the instru-
ment was retuned as necessary. In most
cases, this entire procedure required less
than 1.5 min.
The EPR spectra (X-band, 9.1 GHz)
were measured with 100 KHz field modu-
lation. The Ho magnetic field was centered
at 3230 Oersted. Maximal field scan range
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was 200 Oersted; typical scan rates were 50
Oe/min. Nominal filter time constants
(RC) of 0.1 or 0.3 sec were used.
Microwave power levels were set at low,
nonlimiting values (typically between 5
and 20 mW incident radiation), and nar-
row modulation amplitudes were chosen,
close to those giving maximal signal
response. High receiver gain settings were
needed throughout. All essential experi-
mental conditions, induding initial Cr(VI)
concentration, presence of other ingredi-
ents, and time information, are specified in
the individual figure legends.
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Figure 2 Hydroxylation oftestosterone by cytochrome P450 isozymes in hepatic microsomes from dichromate-treated
female Sprageu-Dawley rats. Microsomes were preparedfrom dichromatre-treated female rats as described inthetext.
Thetestosterone assayand identification ofmetaboliteswerecarried outas referenced in Figure 1. Seetextfor identifi-
cation ofisozymescatalyzingthehydroxylation oftestosteroneatthepositions indicated.
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Figure 5. Production of reactive oxygen species (ROS)
after the addition of Cr(lll) compounds (as CrCI3 and Cr
picolinate) and Cr(VI) as potassium dichromate. The his-
tograms for the Cr(VI) compounds are the same as those
shown in Figure 4. The Cr(lIl) compounds (200 pM) were
added to the A549 cells as described in the text. The his-
tograms represent the appearance of ROS; measure-
ments were made 20 min after the addition of each
compound. Conditions were as for Figure 4. Control was
buffervehicle.
Figure 3 Hydroxylation oftestosterone bycytochrome P450 isozymes in lung microsomesfrom dichromate-treated male
Sprague-Dawley rats. Lung microsomes were prepared from the group of rats referred to in Figure 1. The testosterone
assayand identification ofmetaboliteswerecarried outas referenced in Figure 1.
Fgure 4. Production of reactive oxygen species (ROS) after addition of Cr(VI) as potassium dichromate to A549 lung
cells. The histograms, made using the program, EPICS Cytologic, represent the appearance of ROS afterthe addition of
buffer, and 20and 100 pM Cr(VI) toA549cells. Measurements were made using the CoulterEpicsProfileflowcytometer.
Measurements were made 20 min afterthe addition ofthecompounds. Control was buffervehicle.
The A549 cells were carefully examined
before and after each of the experimental
runs. In no case was there less than 80%
survival as tested by Trypan Blue exclusion
and cell count determinations.
Results
Our studies of the effects of Cr(VI) treat-
ment on testosterone metabolism in hepatic
microsomal preparations from male and
female rats are summarized in Figures 1 and
2. In microsomes from dichromate-treated
male rats there was a significant decrease in
the 6p-hydroxylation of testosterone; the
21-hydroxylation was also decreased. These
specific hydroxylations are carried out
almost exclusively by both cytochrome
P4503A1 (CYP3A1) and cytochrome P450
3A2 (CYP3A2), isozymes previously desig-
nated as cytochromes P450p and P4501
respectively. As there is no constitutive
CYP3A1 enzyme in livers of mature male
rats (26), the initial (and perhaps the
reduced) activities at these positions appear to
be due to the CYP3A2 isozyme. The hydrox-
ylation of testosterone at the 16a position,
catalyzed by cytochrome P4502C 1I
(CYP2C11), previously designated P450h, a
male-specific isozyme, was also significantly
diminished in the male rats following dichro-
mate treatment.
The results ofthe dichromate treatment
ofthe female rats with Cr(VI) prior to iso-
lation ofhepatic microsomes were directly
in contrast to the results in hepatic micro-
somes from the male rats similarly treated.
The hydroxylations catalyzed by isozymes
CYP3A1 and CYP3A2 (at both the 21 and
613 positions) were significantly increased
(Figure 2), as was the testosterone hydroxy-
lation by CYP2B1 (at the 16a position,
and in the formation ofandrostenedione).
This latter enzyme is the type that is also
induced by phenobarbital. The two iso-
forms of the 3A family (CYP3A1 and
CYP3A2) are both present in the female
rat. These two isoforms are very similar in
amino acid content (89% homology) and
in substrate specificity, and their activities
cannot be satisfactorily separated by this
method. For further separation, we are
currently carrying out SDS gel elec-
trophoresis of the microsomal fractions
and making Western blots of the P450
proteins, followed by the use of mono-
clonal antibodies to the two isozymes as
probes. The monoclonal antibodies were
recently developed by Dr. Paul Thomas
and colleagues (personal communication).
These results have been discussed else-
where (3).
In lung microsomes from the dicro-
mate-treated male rats, the specific change
was a significant increase in hydroxylations
carried out by cytochrome P4502B1
(CYP2B1), previously called P450b.
Specifically there were increases in the
hydroxylation activities at the 16a, and
16,B positions and in the production of
adrostenedione (Figure 3).This isozyme
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Figure 6. Effect of vitamin E succinate on production of reactive oxygen species (ROS) in A549 cells after addition of
Cr(VI) as potassium dichromate. Vitamin E succinate (10and 20 pM)was incubated with theA549cells for24 hrpriorto
measurement of the ROS produced by the addition of the Cr(VI) as potassium dichromate to the vitamin-treated cells.
Vitamin E succinate in bufferand the control bufferwere also added to the A549 cells atzerotime. Cr(VI) was added at
100pMconcentration, as indicated. Measurementswere made asdescribed in legendforFigure 1.
was also induced in the hepatic microsomes
from the dichromate-treated female rats.
Generation ofROSFollowing
Addition ofCr(VI) toA549 Cells
Figures 4 to 6 are representative his-
tograms generated by the Epics Cytologic
program, indicating a significant forma-
tion of ROS after K2Cr2O7 addition to
A549 cells, at 20, 100, and 200 pM con-
centrations, with an increase in ROS
with increased dichromate. These figures
all show the response at 20 min. The
ROS produced at 30 min were almost
identical to those at 20 min, indicating
that the reaction was maximal by 20
min. No drop in the ROS levels appears
until the 40-min period, indicating some
leakage of the dye from the cells by this
period, since the oxidized dye is stable.
No ROS were seen with addition of the
chromium compounds (the chloride and
picolinate) to the cells. The fluorescence
of cells containing the picolinate actually
was less than that of untreated control
cells. We detected no effect ofpreincuba-
tion ofthe cells with vitamin E succinate
(20 pM, 24 hr) on the ROS produced
with addition of Cr(VI) (20 or 200 pM)
to the A549 cells (Figure 6). The cells
maintained their homogeneity for the
60-min period ofexposure to dichromate
(figure not shown), indicating no damage
detectable by this measure. All results
shown in these figures are from a typical
experiment.
EPRSpectroscopy
We have used electron paramagnetic reso-
nance spectroscopy (EPR) as a probe to
study the chemical and biochemical events
that occur inA549 lung cells with exposure
to Cr(VI). A representative example of the
application ofEPR techniques to these cells
is illustrated in Figure 7. This spectrum is a
good representative ofresults obtained with
the A549 cells under the conditions out-
lined in "Materials and Methods."
The spectrum in Figure 7 shows at least
five major spectral features (signals) which
we have labeled Peaks I through V, with
field strength increasing from left to right.
Actual Ho values and the exact times (after
mixing) when these signals were recorded
are given in the legend. The spectrum rep-
resents, in approximation, the first deriva-
tive of the resonance absorption, since
magnetic field modulation and phase-sensi-
tive detection were employed. The intensi-
ties of all observed spectral features (peak
amplitude, or integrated areas, when used)
exhibit an absolute dependence on the con-
centration of the A549 cells. With buffer
medium alone, only a flat "baseline" spec-
trum is seen. Furthermore, all signals also
depend on the initial Cr(VI) concentration
(see below). A free radical standard
(DPPH) has been included in the measure-
ment. Under the instrumental conditions
used, this resonance was centered at 3204.9
Oe (Figure 7).
Three of the major EPR signals (Peaks
I-III) were observed at magnetic fields
lower than that of the marker, and thus
with g-values greater than that of the free
electron value. Together with other infor-
mation, this suggests that the species
responsible for this part of the EPR spec-
trum have the characteristics offree radical
species. On the other hand, the rest ofEPR
signals, which are found at higher fields
(Peaks IV and V), and thus to the right of
the marker position, are consistent with
complexes of paramagnetic transition ions
and are no doubt Cr(V) species.
Some of the chemical and biochemical
complexities caused by the exposure ofthe
A549 cells to Cr(VI) are seen in Figure 8a-
d Peak amplitudes of the five major EPR
peaks previously defined are plotted as a
function oftime. These data were obtained
3187 3201.0 3218A
323 344
Figure 7. EPR spectrum ofA549 cells after exposure to Cr(VI). Signal amplitudes, in relative units(au), are plotted as a
function of the HO field in [Oersted]. The reaction was started by adding Cr(VI) (as K2Cr207 in buffered solution) to har-
vested and resuspended A549 cells at "zerotime." Atotal of2.2 x 107 cells was used, in avolume of0.43 ml. Final con-
centrations atzerotimewere: Cr(VI) 116pM, Na+(asNaCI) 57mM, Na2-EDTA4.2 mM, phosphate 4.0 mM. Field values
ofthe prominent spectral features (at constant microwavefrequency) are indicated in the graph(Peaks l-V). They were
recorded -actual times aftermixing-asfollows: Peak1(3184.7 Oe), at2.98 min; Peak 11(3201.9 Oe), at3.3 min; Peak
III (3218.4 Oe), at3.7 min; Peak IV(3233.9 Oe), at3.9 min; and PeakV(3244.6 Oe), at4.17 min. All these measurements
were performed at 21'C. The inserted marker indicatesthefield position of an organic free radical standard (crystalline
1,1-diphenyl-2-picryl-hydrazyl, DPPH, with a g-value, g = 2.0036 ±0.0003) underthe conditions ofthis experiment. This
narrow-line resonancesignal ofthis markerwas observed at3204.9 Oe.
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Figure 8 EPR spectra of A549 cells after exposure to Cr(VI): time course. Peak amplitudes (arbitrary units, au),
sponding tothe Peak toVsignals defined in Figure 7, are plotted as a function oftime after mixing, in min.The)
determined directly from the recorded spectra; no attempts were made here to obtain and use 'refined values'
nonlinearcurve-fitting procedures. The spectra were recorded asdescribed. Approximately2 x 107freshlyharveste
were resuspended in 0.18 ml phosphate-buffered saline. Cr(VI), as K,Cr20,, was added in phosphate buffer (0.1
7.2) to obtain the final Cr(VI) concentrations specified below. Final phosphate concentration was about 58 mM. /
panels have identical X-and Y- axes. In each panel, thefollowing codes are used: Peak I, open circles, solid line; F
filled circles, long dashes; Peak Ill, opentriangles, medium-length dashes; Peak IV, filled triangles, shortdashes; F
open squares, dotted line. Final Cr(Vl)concentrations for exposure at "zerotime" were(a) 23 pM; (b) 58 pM; (c) 1 '
(d 233 pM.
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Figure 9. EPR spectra of A549 cells after exposure to Cr(VI): effects of dimethylsulfoxide (DMS0). (a) Mean
observed amplitudes ofPeak and Peak II is plotted as afunction oftime[min] aftermixing. DMSO sample: open
solid line; control sample(no DMSO): filledcircles, broken line. (b)Theamplitude ofPeakV is plotted, in analogou
ion as a function oftime after mixing. DMSO sample: open circles, solid line; control sample (no DMSO): filled
broken line. Experimental conditions used: 2.0 x 107cells in 0.43 ml final volume. Cr(VI) 116 pM; DMSO 320 mM.
from a set ofexperiments in which the ini-
tial Cr(VI) concentration was varied about
10-fold, from 23 to 233 FiM final concen-
tration, while the concentration of A549
cells was constant. Detailed analysis shows
that the maximal amplitudes ofeach ofthe
major signals varied strongly, and in com-
plicated ways, with the Cr(VI) concentra-
tion. Also, these amplitudes were reached
at significantly different times after mixing.
In spectra from the highest concentra-
tion of Cr(VI) used, the signals are
detectable for up to 20 min after mixing,
while at the low concentration, these sig-
nals last only for about 10 min, indicating
that the rates ofdecay are also different.
We have also examined the effects of
the addition of a several additional com-
pounds, including dimethylsulfoxide and
inorganic anions (phosphate and sulfate) to
the A549 cells, by adding them to the
extracellular medium. In Figure 9, we show
the effects on the Cr(VI)-induced spectra
(233 pM Cr), ofthe addition ofdimethyl-
sulfoxide (DMSO) to the cellular medium.
Panel A shows the effects seen on the mean
25 of the amplitudes of Peaks I and II; panel B
shows that the opposite effect is seen on
the amplitude of Peak V. Details are out-
corre- lined in the figure legend.
y were
" using DiScussion
dcells The results seen in the studies of in vivo
M, pH effects of Cr(VI) were of two kinds: a
Peak II change in critical isozyme activities, which
PeakV, may be detrimental for the animal under
16 uM; some circumstances; and the formation of
ROS and paramagnetic species which are
known to be toxic. That these effects on
the isozymes are seen in vivo in both liver
and lung after treatment of rats with rela-
tively low doses ofCr(VI) indicates that the
liver at least responds somewhat differently
than predicted by the in vitro studies.
Relatively high Cr(VI) concentrations were
required in the in vitro system to reduce
the total cytochrome P450 content (2).
The findings of significant changes in
the rat hepatic and lung microsomal
isozymes of the P450 family of enzymes
following in vivo exposure to dichromate
b - indicate that the effects of hexavalent
chromium compounds can indude impor-
tant indirect effects, such as changes in the
40 first step ofmetabolism (the hydroxylation)
of other xenobiotics. The liver enzymes,
and specifically the P450 family are the
major site of xenobiotics metabolism. The
cirfclths substrates metabolized by the 3A P450
is fash- gene family include many carcinogens, i.e.,
circles, CYP3A1 metabolizes aflatoxin B, and
acetylaminofluorene, as well as cortisol,
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progesterone, and testosterone. This gene
family is induced by steroids and has the
most widespread substrate activities of all
the P450 families. Aflatoxin B, is a xenobi-
otic to which we are frequendy exposed (in
peanut butter), so changes in its rate of
metabolism could cause concern.
The overall effects of these changes in
specific hepatic P450s on metabolism of
other xenobiotics cannot be effectively
assessed, however, without information on
the fate of the phase I products (epoxides
and/or hydroxylated metabolites) resulting
from P450 oxidations. Any such changes
could alter the equilibria ofthe initial reac-
tions. For example, chromate has been
shown to inhibit glutathione reductase
activity in erythrocytes (27) and perhaps
this is also true in other tissues. Our results
emphasize the differing effects ofchromate
treatment on lung. and on one other tissue,
liver in male rats. The interesting opposing
effects of Cr(VI) on liver enzymes in male
and female rats, however, were not unex-
pected, as steroids are metabolized differ-
ently in the two sexes.
CYP2B1, which was increased in activ-
ity in lungs of Cr(VI)-treated male rats, is
active in lung Clara cells. The lung is the
first site of inactivation of inhaled xenobi-
otics, and the increased activity of this
form of P450 appears to be a defense
action. Increases in CYP2B1 can cause
increased metabolism of xenobiotics such
as aniline, barbiturates, and benzo[a]-
pyrene and other compounds in the lung.
However, ifthe companion enzyme, epox-
ide hydrolase, is not also increased, there
could be increased production of toxic or
carcinogenic intermediates, such as epox-
ides. This enzyme is also induced by phe-
nobarbital treatment and is relatively
nonspecific in its substrate activities. The
mechanism of this increased activity was
not addressed in the current study.
The formation of an abundance of
reactive oxygen species caused by Cr(VI)
addition to the A549 lung cells indicates
that the reduction ofhexavalent chromium
is not a simple process in which some
Cr(V) may be formed which is then
reduced to Cr(III) complex(es) that react
with DNA. Rather, there is a possibility of
many interactions of reactive species with
intracellular moieties. Several methods of
identifying these species are now being
tried in our laboratory. The lack ofeffect of
vitamin E on the ROS formation was
unexpected and suggests that the species
produced do not result from lipid peroxi-
dation. Vitamin E added to V79 cells in
culture at the same concentration by
Sugiyama (28) reduced the number ofsin-
gle strand breaks in DNA caused by hexa-
valent chromate. This suggests that the
strand breaks are not caused directly by the
reactive oxygen species.
We have also carried out preliminary
studies in which we exposed A549 cells to
several concentrations ofCr(VI) as dichro-
mate for 3 hr. The dichromate exposure
was followed by washout of the chromate
with subsequent growth in a dichromate-
free medium for 24 hr, followed by RNAse
treatment and staining of the cells with
propidium iodide. We found an abnormal
accumulation of cells in S-phase in cells
exposed to 5 pM dichromate. This is in
agreement with Costa (29) who also
reported a build-up of S-phase cells in
Chinese hamster ovary cells after treatment
with several metals. Our work with the cell
cycle analysis is still in progress.
EPR Spectroscopy
EPR spectroscopy detects the presence of
paramagnetic entities, allows their quanti-
tation, and affords the characterization of
kinetic features of their formation as well
as their decay processes. Compounds that
can be investigated exhibit paramagnetism
that is derived either from the electron
configuration of transition metal ions in
certain valence states and specific coordi-
nation geometries, or from molecular
unpaired electrons in other molecules, i.e.,
free radical species (S=1/2). Different
species can be observed side by side, and
their individual characteristics can be eval-
uated. However, a definitive chemical
characterization of the molecules causing
the observed resonance absorption solely
on a spectroscopic basis may be difficult.
EPR spectroscopy has been successfully
applied to studies of the transition ele-
ment, chromium, in its many states and
levels of complexation for many years.
Most chromium compounds were found
to have g-values close to the "free electron"
value, often at slightly higher fields (i.e.,
lower g-values); observed line widths are
often narrow, especially for Cr(V) species.
As is characteristic for transition metal
ions, the actual spectral features are quite
sensitive to the nature of the ligands, the
geometry of coordination, and even the
matrix in which these complexes are stud-
ied. These factors influence the shape of
the resonance absorption; relaxation times
and temperature play additional important
roles. Finally, for different, purely geomet-
ric reasons, the actual EPR spectra for any
given material obtained in liquid solution
(as we have used here) differ substantially
from spectra obtained in the frozen state
(with "immobilized" quasi-random orien-
tation of the spins). Thus the g-values in
immobilized and randomly oriented sam-
ples are inherently very different from the
g-values ofsolution spectra.
Of particular interest in these studies
were paramagnetic entities containing
chromium in a formal (V) valence state
with a 3di electron configuration. These
coordination complexes play recognized,
but not understood, roles as intermediates
in the reduction of Cr(VI) compounds to
complexes ofthe thermodynamically stable
Cr(III). Recent reports include the obser-
vation of tetraperoxo-chromate(V) as a
product of the reduction of Cr(VI) (4,5)
and a number of studies of Cr(V) entities
in a variety of chemical and biochemical
systems, with reported g-values around
1.98 (4-6). Frozen samples were usually
employed to facilitate detection and to cir-
cumvent problems of chemical stability of
the Cr(V) complexes.
The aim of our application of EPR
spectroscopy was to investigate effects of
Cr(VI) in A549 cells, under conditions
that are as close as possible to physiological
conditions. These techniques provide the
most direct experimental access to the
measurements ofthe paramagnetic species.
The approach requires the operation ofthe
EPR spectrometer close to the fundamen-
tal limitations of the method, especially
regarding detection sensitivity. It necessi-
tates compromises in virtually all instru-
mental settings (choice of microwave
power levels, modulation amplitudes, scan
rates and amplifier gain). Use of cell sus-
pensions in solution allowed us to look
closely at the reactions in which the
observed paramagnetic species [including
Cr(V) species] respond kinetically in real
time, under nearly physiological condi-
tions, and relatively unperturbed by the
measurements. We have not used spin-
trapping agents, so as not to shift equilib-
ria or alterkinetic information.
The EPR spectrum seen in Figure 7 is
a good example of our results obtained
with theA549 cells under our defined con-
ditions (see Materials and Methods). Five
major spectral features (signals) can be
identified (Peaks I to V). Each of these
exhibits its own complex kinetics of for-
mation and decay. A representative sum-
mary ofthese kinetic aspects [amplitude vs
time, as a function of initial Cr(VI) con-
centration] is shown in Figure 8a-d.
Peaks I to III can be classified, spectro-
scopically, as generated by free radical
species. Like all species we have observed
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in the A549 cells, they are transient
species, varying greatly in rates of forma-
tion and decay. It must be stressed, how-
ever, that no definite assignments of
chemical structures from the signals is
possible. More information is required
than the spectroscopic data provide.
Likewise, the kinetic results which can
provide crucial information for under-
standing ofsome of the dynamic intracel-
lular processes involving the paramagnetic
species, do not allow definition of the
chemical structures. Clearly, much further
work is needed to positively identify the
species responsible for Peaks I to III in the
A549 cells. Work toward this aim is in
progress.
The three signals (Peaks I to III)
which we have found in these lung cells
following Cr(VI) addition have not been
reported previously in any known system .
It is not known whether these signals are
unique to lung cells, because other organs
have not been examined by EPR tech-
niques. Peaks IV and V, however, indicate
by their resonance absorption at higher
magnetic fields than the free electron
value that they are caused by a Cr(V)
entity. Thus, our findings are in agree-
ment with the reports of others (4,5,7,8)
that some form of Cr(V) is found in
chemical and biochemical systems on the
reduction ofCr(VI).
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